9,10-epoxy-9,10-dihydrophenanthrene: RN given refers to cpd without isomeric designation
ID Source | ID |
---|---|
PubMed CID | 104975 |
CHEMBL ID | 48158 |
CHEBI ID | 25957 |
SCHEMBL ID | 14870743 |
MeSH ID | M0135119 |
Synonym |
---|
phenanthrene, 9,10-dihydro-9,10-epoxy- |
9,10-epoxy-9,10-dihydrophenanthrene |
1a,9b-dihydro-1-oxa-cyclopropa |
9,10-dihydro-9,10-epoxyphenanthrene |
1a,9b-dihydrophenanthro[9,10-b]oxirene |
CHEBI:25957 , |
phenanthrene 9,10-oxide |
1a,9b-dihydro-1-oxa-cyclopropaphenanthrene |
phenanthrene-9,10-epoxide |
9,10-epoxy-9,10-dihydro-phenanthrene |
phenanthro(9,10-b)oxirene, 1a,9b-dihydro- |
9,10-phenanthrene oxide |
1a,9b-dihydrophenanthro(9,10-b)oxirene |
ccris 1986 |
phenanthrene-9,10-oxide |
585-08-0 |
CHEMBL48158 |
AKOS006279295 |
1a,9b-dihydrophenanthro[9,10-b]oxiren |
SCHEMBL14870743 |
9,10- dihydro-9,10-epoxy-phenanthren |
phenanthro[9,10-b]oxirene, 1a,9b-dihydro- |
PXPGRGGVENWVBD-UHFFFAOYSA-N |
phenanthrene 9, 10-oxide |
Q27109898 |
DTXSID201004762 |
Excerpt | Relevance | Reference |
---|---|---|
" One of the diastereoisomeric forms of the methyl ester of the mercapturic acid is identical with the ester of the mercapturic acid excreted by rats dosed with the epoxide or by rats and rabbits dosed with phenanthrene." | ( METABOLISM OF POLYCYCLIC COMPOUNDS. THE METABOLISM OF 9,10-EPOXY-9,10-DIHYDROPHENANTHRENE IN RATS. BOYLAND, E; SIMS, P, 1965) | 0.49 |
Class | Description |
---|---|
phenanthrene oxide | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.20) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |